All Posts
[Abstract Only] Meta-Analysis: Prevalence of Harmful Diagnostic Errors in Hospitalized Adults
3 May, 2020 | 21:45h | UTCPrevalence of harmful diagnostic errors in hospitalised adults: a systematic review and meta-analysis – BMJ Quality & Safety (link to abstract – $ for full-text) (via @brhospitalist)
Related Commentary on Twitter
Systematic review of 22 UK studies found that 14 common diagnoses, including malignancy and pulmonary embolism, accounted for more than half of missed or delayed diagnoses in hospital patients. @BMJ_Qual_Saf https://t.co/1JypG7idlJ pic.twitter.com/YxKeiZr5x0
— AHRQ (@AHRQNews) May 1, 2020
Classification of the Cutaneous Manifestations of COVID‐19 with 375 Illustrative Cases
1 May, 2020 | 03:43h | UTCRelated: Journal articles on coronavirus with relevance for skin diseases and dermatology – Centre of Evidence Based Dermatology, University of Nottingham AND Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak – Journal of the American Academy of Dermatology
Great atlas with the different cutaneous manifestations of Covid-19.
CO-RADS – A Categorical CT Assessment Scheme for Patients with Suspected COVID-19
1 May, 2020 | 03:48h | UTC
New CDC Guidance: Care for Breastfeeding Women with Covid-19
1 May, 2020 | 03:53h | UTCCare for Breastfeeding Women – Centers for Disease Control and Prevention
Study Estimates the Impact of Social Distancing and School Closures on the Dynamics of the COVID-19 Outbreak
1 May, 2020 | 03:39h | UTCChanges in contact patterns shape the dynamics of the COVID-19 outbreak in China – Science
Related Commentary on Twitter
Just published: Major lessons from China on social distancing; school closing; children, young vs. adult impact for #COVID19https://t.co/wd3umeh46m
Social distancing: 7-8 X contact reduction
School closure: 40-60% reduction peak + delay
Continuum of age @ScienceMagazine pic.twitter.com/scrsvF3Pkq— Eric Topol (@EricTopol) April 29, 2020
Study: Within 19 Days After Symptom Onset, 100% of Patients Test Positive for IGG
1 May, 2020 | 03:33h | UTCAntibody responses to SARS-CoV-2 in patients with COVID-19 – Nature Medicine
Commentary: Expert reaction to antibody response in COVID-19 patients – Science Media Centre
Preprint Study Suggests Children May Be as Infectious as Adults
1 May, 2020 | 03:36h | UTC
Small Observational Study Suggests Prophylactic LMWH Can Prevent COVID‐19 Disseminated Intravascular Coagulopathy
1 May, 2020 | 03:26h | UTCCOVID‐19 Coagulopathy in Caucasian patients – British Journal of Haematology
Treatment Considerations for COVID-19: A Critical Review of the Evidence
1 May, 2020 | 03:20h | UTC
New Model to Track Covid-19 Spread
1 May, 2020 | 03:29h | UTCPopulation flow drives spatio-temporal distribution of COVID-19 in China – Nature
Commentary: Researchers devise new model to track COVID-19’s spread – Yale News
[Abstract Only] Cohort Study: Effect of Hydroxychloroquine and Azithromycin on the QT Interval in Patients with Covid-19
1 May, 2020 | 03:10h | UTCThe Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection – Circulation: Arrhythmia and Electrophysiology (link to abstract – $ for full-text)
COVID-19 and the Cardiovascular System: Implications for Risk Assessment, Diagnosis, and Treatment Options
1 May, 2020 | 03:18h | UTCRelated Guidelines: COVID-19 rapid guideline: acute myocardial injury – National Institute for Health and Care Excellence AND ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology AND Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology
Perspective: Urging Caution on Remdesivir
1 May, 2020 | 03:07h | UTCUrging Caution On Remdesivir – Forbes
Related: About Remdesivir and About “Game-Changers” – Science Translational Medicine AND Conflicting Remdesivir Trial Results Released; Experts Urge More Research – Health Policy Watch AND Is remdesivir a miracle drug to cure coronavirus? Don’t get your hopes up yet – The Conversation AND PulmCrit- First placebo-controlled RCT on remdesivir for COVID-19 – PulmCrit AND Remdesivir: the antiviral drug is being touted as a possible coronavirus treatment – but will it work? – The Guardian
“While I have enormous respect for the Institutes and their leaders, releasing the preliminary news without sharing the data behind it is highly irresponsible.”
Review: Neurologic Comorbidities and Complications in Patients Hospitalized for COVID-19
1 May, 2020 | 03:03h | UTCRelated Studies: Neurologic Features in Severe SARS-CoV-2 Infection – New England Journal of Medicine AND Neurologic Manifestations Common in Hospitalized Patients with Covid-19 (study and commentaries)
COVID-19: ICU Delirium Management During SARS-CoV-2 Pandemic
1 May, 2020 | 02:54h | UTCCOVID-19: ICU delirium management during SARS-CoV-2 pandemic – Critical Care
ACR Guidance for the Management of Patients with Rheumatic Disease During the COVID‐19 Pandemic
1 May, 2020 | 02:42h | UTC
We Need to Flatten the ‘Other’ Coronavirus Curve, Our Looming Mental Health Crisis
1 May, 2020 | 02:45h | UTCRelated: Health Care Workers Seek to Flatten COVID-19’s ‘Second Curve’—Their Rising Mental Anguish
Clinical Determinants for Fatality of 44,672 Patients with COVID-19
1 May, 2020 | 02:48h | UTCClinical determinants for fatality of 44,672 patients with COVID-19 – Critical Care
AAN Recommendations for Closure of Patent Foramen Ovale in Secondary Stroke Prevention
1 May, 2020 | 02:34h | UTCNews Release: AAN updates recommendation on closure of common heart defect after stroke – American Academy of Neurology
Systematic Review: No Evidence to Support the Use of Aspirin for the Prevention of Dementia
1 May, 2020 | 02:38h | UTCRelated Randomized Trial: Aspirin Not Beneficial for Reducing the Risk of Dementia, MCI, or Cognitive Decline
Randomized Trial: Remdesivir Not Beneficial for Adults with Severe COVID-19
30 Apr, 2020 | 04:31h | UTCCommentaries: First randomized trial of remdesivir suggests antiviral drug is not associated with significant clinical benefits, more research needed – The Lancet AND Expert reaction to trial of remdesivir in adults – Science Media Centre
See also: [Not Published Yet] NIH Study Shows Remdesivir Accelerates Recovery from Advanced COVID-19
Related Commentary on Twitter
With all the hype about Remdesivir today @TheLancet has decided to lift the embargo and release this placebo-controlled multicenter study done in China that showed no benefit https://t.co/ZdmKfnWLyw
— Carlos del Rio (@CarlosdelRio7) April 29, 2020
Pooling of Samples for Testing for SARS-CoV-2 in Asymptomatic People
30 Apr, 2020 | 04:25h | UTCPooling of samples for testing for SARS-CoV-2 in asymptomatic people – The Lancet Infectious Diseases AND Commentary: Virologists show that sample pooling can massively increase coronavirus testing capacity – Saarland University
Related Preprint Study: Smart Pooled sample Testing for COVID-19: A Possible Solution for Sparsity of Test Kits – medRxiv AND Commentary: ‘Smart sample pooling’ for COVID-19 could solve test kit shortage problem – News Medical
[Not Published Yet] NIH Study Shows Remdesivir Accelerates Recovery from Advanced COVID-19
30 Apr, 2020 | 04:28h | UTCCommentaries: Hopes rise on coronavirus drug remdesivir – Nature AND The COVID-19 research news rollercoaster is running again: STAT News + Gilead’s remdesivir – HealthNews Review
See also: Randomized Trial: Remdesivir Not Beneficial for Adults with Severe COVID-19
Audio Interview: Loosening Covid-19 Restrictions
30 Apr, 2020 | 04:17h | UTCAudio Interview: Loosening Covid-19 Restrictions – New England Journal of Medicine
Men with COVID-19 Twice More Likely to Die than Women
30 Apr, 2020 | 04:21h | UTCNews Release: COVID-19 study shows that men have over double the death rate of women – Frontiers